Next Article in Journal
Special Issue “Molecular Mechanisms of Bisphenol A Toxicity and Effects of Environmental Levels on Health”
Next Article in Special Issue
Parkinson’s Disease: Exploring Different Animal Model Systems
Previous Article in Journal
Clinical and Genetic Characteristics of Calvarial Doughnut Lesions with Bone Fragility in Three Families with a Reccurent SGMS2 Gene Variant
Previous Article in Special Issue
Fisetin, a Natural Polyphenol, Ameliorates Endometriosis Modulating Mast Cells Derived NLRP-3 Inflammasome Pathway and Oxidative Stress
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 9
10.3390/ijms24098036
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Influence of Leptin on the Secretion of Growth Hormone in Ewes under Different Photoperiodic Conditions

by
Maciej Wójcik
1,
Agata Krawczyńska
1,
Dorota Anna Zieba
2,
Hanna Antushevich
1 and
Andrzej Przemysław Herman
1,*
1
The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Instytucka 3, 05-110 Jabłonna, Poland
2
Department of Nutrition and Animal Biotechnology, and Fisheries, Faculty of Animal Sciences, University of Agriculture in Krakow, 31-120 Krakow, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(9), 8036; https://doi.org/10.3390/ijms24098036
Submission received: 6 March 2023 / Revised: 21 April 2023 / Accepted: 27 April 2023 / Published: 28 April 2023
(This article belongs to the Special Issue Model Animals in Human Diseases)
Browse Figure
Versions Notes

Abstract

:
Leptin is an adipokine with a pleiotropic impact on many physiological processes, including hypothalamic-pituitary-somatotropic (HPS) axis activity, which plays a key role in regulating mammalian metabolism. Leptin insensitivity/resistance is a pathological condition in humans, but in seasonal animals, it is a physiological adaptation. Therefore, these animals represent a promising model for studying this phenomenon. This study aimed to determine the influence of leptin on the activity of the HPS axis. Two in vivo experiments performed during short- and long-day photoperiods were conducted on 12 ewes per experiment, and the ewes were divided randomly into 2 groups. The arcuate nucleus, paraventricular nucleus, anterior pituitary (AP) tissues, and blood were collected. The concentration of growth hormone (GH) was measured in the blood, and the relative expression of GHRH, SST, GHRHR, SSTR1, SSTR2, SSTR3, SSTR5, LEPR, and GH was measured in the collected brain structures. The study showed that the photoperiod, and therefore leptin sensitivity, plays an important role in regulating HPS axis activity in the seasonal ewe. However, leptin influences the release of GH in a season-dependent manner, and its effect seems to be targeted at the posttranscriptional stages of GH secretion.

1. Introduction

Obesity in humans modulates the activity of many physiological pathways at different levels, from the secretion of basic hormones to changes in sensitivity to the hormone’s actions. One such hormone is leptin, a pleiotropic cytokine-like hormone also considered to be involved in the modulation of the hypothalamic-pituitary-somatotropic (HPS) axis activity; however, experimental data from studies examining the role of leptin in HPS axis modulation are ambiguous. This axis is one of the most important hormonal axes and is key in regulating metabolic processes in mammalian organisms. HPS axis activity disturbances, including both lowered and increased activity, affect metabolism, immunology, and reproduction [1]. In rats, leptin has been found to increase growth hormone (GH) secretion both at baseline and after growth hormone-releasing hormone (GHRH) stimulation [2]. Additionally, a study of cow adenohypophyseal explants showed that GH levels were lower after leptin stimulation. It was also demonstrated that the effects of leptin on the HPS axis depend on the nutritional status of the animal [3]. The results emphasize the importance of nutritional status and leptin as a hormone related to HPS axis activity status.
Leptin is mainly secreted by white adipose tissue. Its plasma concentration positively correlates with the amount of adipose tissue in the organism [4]. Leptin regulates feeding behavior and is often called the satiety hormone because it suppresses appetite and increases the metabolic rate primarily by acting through central pathways [4]. This hormone also regulates reproductive function and plays a role in growth processes, proinflammatory immune responses, angiogenesis, and lipolysis [5,6]. It was found that a decrease in tissue sensitivity to leptin leads to the development of obesity and metabolic disorders, such as insulin resistance and dyslipidemia. Mechanisms underlying the development of leptin resistance may include mutations in the gene encoding leptin and its receptors, as well as in proteins involved in the self-regulation of leptin synthesis and blood-brain barrier (BBB) permeability [7].
In seasonal animals, changes in day length are accompanied by changes in many physiological systems [8], including the HPS axis [9] and immunity [10]. A significantly higher GH plasma concentration was observed during the long-day (LD) photoperiod [11,12]. The seasonality of sheep has a crucial impact on how leptin influences these organisms because, during the LD season, natural leptin resistance is observed in these animals [10,13,14,15]. Leptin resistance involves the insensitivity of specific tissues and glands to this hormone and is characterized by hyperphagia, reduced energy expenditure, and hyperleptinemia. The mechanisms of both pathological (in obese humans) and physiological day length-dependent leptin resistance (seasonal animals, e.g., in sheep) are still not fully understood. This natural leptin resistance also seems to influence the HPS axis activity. However, earlier studies indicate that melatonin is an important factor that may act directly on the hypothalamus and change leptin sensitivity. The results showed that both melatonin receptor deficiency and a decrease in the levels of this hormone lead to leptin resistance in mice and rats, respectively [16,17].
Due to the seasonally variable sensitivity of sheep to the action of leptin, it could be hypothesized that the modulatory effect of leptin on HPS axis activity could be photoperiod-dependent. Therefore, this study was performed using a sheep model and was designed to determine the modulatory role of leptin on the secretion of GH and the expression of genes associated with the HPS axis activity in the hypothalamic nuclei, including the arcuate nucleus (ARC) and paraventricular nucleus (PVN), and the anterior pituitary (AP) during short-day (SD) and LD photoperiods.

2. Results

2.1. The Effect of Leptin and Photoperiod on the Plasma Concentration of GH

The circulating concentration of GH was lower (p < 0.05) during the LD photoperiod than during the SD photoperiod. Injection of leptin reduced (p < 0.05) the blood level of GH only during the SD photoperiod, whereas during the LD period, the concentration of GH was not affected by leptin treatment. Moreover, it was found that the circulating concentration of GH increased (p < 0.05) in the control ewes during the experiment performed during the SD photoperiod. It is worth noting that time-dependent changes in GH secretion were not observed in the ewes during the LD photoperiod (Figure 1).

2.2. Gene Expression

2.2.1. The Effect of Leptin on the Relative Expression of HPS Axis-Associated Genes in the ARC and PVN

GHRH mRNA expression in the ARC was higher (p < 0.05) during the LD photoperiod. Leptin did not influence the expression of GHRH regardless of the photoperiodic condition. Expression of the long form of the leptin receptor (LEPR) encoding gene in the ARC was lower (p < 0.05) during the LD photoperiod than during the SD period. During both photoperiods, leptin treatment did not change LEPR expression. Somatostatin (SST) mRNA expression in the PVN was higher (p < 0.05) during long days. LEPR expression in the PVN did not differ between the photoperiods among the control groups. However, during the SD photoperiod, treatment with leptin caused an increase in LEPR expression (p < 0.05) in the PVN, while LEPR mRNA expression was lower during long days (p < 0.05) in the leptin-treated animals than in the control group (Table 1).

2.2.2. The Effect of Leptin on the Relative Expression of HPS Axis-Associated Genes in the AP

Growth hormone-releasing hormone receptor (GHRHR) mRNA expression did not differ between photoperiods among the control groups. The expression of GHRHR was also not influenced by leptin treatment, regardless of the season. Somatostatin receptor (SSTR) 1 mRNA expression was higher (p < 0.05) during short days in the control groups. Leptin treatment did not influence the expression of SSTR1 regardless of the season. SSTR2 expression was higher during the LD photoperiod (p < 0.05). Leptin treatment increased SSTR2 expression only during the LD photoperiod (p < 0.05). SSTR3 expression did not differ between the photoperiods among the control groups. Leptin treatment did not cause any difference in SSTR3 expression during either photoperiod. Differences in SSTR5 expression were not observed between the photoperiods among the control groups. Additionally, leptin treatment did not influence SSTR5 expression regardless of the photoperiod. GH mRNA expression was higher during the SD photoperiod (p < 0.05) than during the LD period in the control group. Leptin treatment did not influence the expression of GH regardless of the photoperiod (Table 2). LEPR mRNA expression was higher during the SD photoperiod; however, administration of leptin did not affect the mRNA expression of this gene.

3. Discussion

The results of the present study showed that intravenous (i.v.) administration of leptin had an inhibitory effect on GH release during the SD photoperiod; however, leptin treatment did not influence the circulating concentration of GH during the LD period in sheep [3]. It is worth mentioning that an in vivo study on rodents suggested that leptin has a stimulatory effect on GH secretion. An experiment investigating male rats showed that intracerebroventricular (ICV) infusion of leptin stimulated both spontaneous pulsatile GH secretion and the GH response to GHRH [2], and a study investigating leptin-deficient obese mice (ob/ob) showed that these animals were characterized by decreased circulating GH concentration and pituitary GH and ghrelin receptor (GHS-R) mRNA levels, whereas hypothalamic GHRH and SST expression in these animals did not differ from that in lean controls [18]. A study on castrated estrogen-treated yearling male sheep found that leptin administration increased GH pulse amplitudes and mean concentrations of circulating GH [19]. Since we did not measure pulsatile GH release, the results of the current study cannot be compared to the mentioned results regarding pulsatile GH secretion. However, basal GH secretion is the most studied in other studies, and almost all of our experiments, and this information is sufficient to show the effect of leptin on GH secretion. These results suggest that the effects of leptin on GH secretion could also be dependent upon the species, sex, and/or hormonal status of an animal. Generally, the effect of leptin on GH secretion is still elusive and seems to also be dependent upon the use of an in vivo vs. an in vitro experimental model. An in vitro study on primary cultured ovine somatotrophs showed that, although short-term leptin treatment did not influence GH release, long-term leptin treatment suppressed GH secretion [20]. Moreover, the positive effect of leptin on GHRH-induced GH release has been reported in studies of primary monolayer cultures of pituitary cells in rats [21]. However, opposite results have been published by Roh et al. (2001) [22], who observed that leptin has a negative effect on GH secretion stimulated by GHRH from primary sheep cell culture. The results of an in vitro study on cultured GH3 cells showed that leptin inhibited the basal GH secretion of GH3 cells, and it was suggested that the inhibitory effect of leptin on GH synthesis and secretion might be related to the decreasing level of intracellular free Ca(2+) [23]. An ex vivo study on bovine AP explants showed that leptin could directly act on the AP to modulate GH release, and this effect was dependent upon the fasted vs. normal-fed nutritional history of the cattle [3]. It was found that higher doses of leptin led to lower basal GH secretion than control treatment in tissues collected from normal-fed cows. However, GH release from AP explants from fasted cows treated with the lowest dose of leptin was higher than that from control explants, but larger doses had no effect. Moreover, leptin caused an inversely related, dose-dependent increase in GHRH-mediated GH release in tissues from normal-fed cows. These results may have been due to differences in physiology between somatotrophs maintained for a short time (explants) and the long-term (primary) culture [24].
Our results obtained in ewes from the present experiment suggest that the effect of leptin on GH secretion is highly dependent upon the photoperiodic condition. It is worth noting that the leptin–basal concentration was at a significantly higher level during the LD period [25]. The higher concentration of leptin in plasma was also maintained at every time point of the experiment in the group treated with leptin [25]. These results are consistent with those reported in the paper by Marie et al. (2001) [26]. She showed that during the LD season, the concentration of leptin in blood plasma was 180% increased than during the SD season, but this change was not associated with the anorectic action of leptin. During this period, when readily accessible food is abundant, sheep exhibit increased appetite and appear to be insensitive to the high concentrations of leptin that result from increased adiposity. Seasonal leptin resistance allows these animals to live in changing climates and store energy that they can use during periods of reduced food availability. During the autumn and winter, sheep exhibit physiological sensitivity to leptin, and their appetite adjusts in proportion to their nutritional status [13]. In the present experiments, leptin treatment failed to influence GH secretion during the LD season when administered using the same dose as that used during the SD period. This finding suggests that some type of leptin resistance in the pituitary occurs during the SD photoperiod. Similar observations were made by Szczesna et al. (2011) [27]. This group reported on the coexistence of leptin resistance in the pituitary with the maintenance of leptin sensitivity in the hypothalamus based on SOCS3 expression during SD seasons. Although many mechanisms may cause leptin resistance, one of them is certainly the lower sensitivity of cells/tissues to the action of leptin associated with the reduction in the expression of its receptor, which is responsible for leptin signal transduction; this resistance is also accompanied by an increased concentration of leptin in the blood. The results of those experiments demonstrated that leptin infuses centrally into the third brain ventricle, affecting the expression of SOCS3 factors in a seasonal and tissue-dependent manner. These results suggested that central leptin infusion alters the expression of SOCS3 factors in sheep, which leads to alterations in the hypothalamic and pituitary sensitivity to the actions of leptin [13]. The importance of LEPR in regulating AP function was suggested by studies that showed the prevalence of both long and common forms of mRNA and leptin receptor protein in normal AP cells [28]. Our experiment showed that long-day ewes are characterized by significantly lower gene expression of the LEPR gene in the AP than short-day ewes. Lower expression of the LEPR gene in the AP may explain the lack of effect of leptin treatment on the circulating concentration of GH in long-day ewes. It is worth mentioning that long-day ewes showing lower LEPR gene expression in the AP were also characterized by lower circulating concentrations of GH. This result supports the result of a study on rodents that reported that mice with the deletion of a long LEPR isoform showed a substantial decrease in the circulating concentration of GH [29]. It is worth mentioning that the occurrence of physiological LEP resistance has been reported in seasonal animals, including sheep [13].
Importantly, leptin could influence the secretion of GH not only by directly influencing somatotropic cells in the pituitary gland but also by interfering with the hypothalamic nuclei involved in the control of GH secretion. Although thus far it is not entirely clear whether leptin has to penetrate brain barriers to exert its central effects, it is generally accepted that brain access is important for leptin to exert its physiological actions. Due to its size (16 kDa), leptin seems unable to diffuse passively through brain barriers. However, it has been previously reported that leptin has direct access to circumventricular organs, including LEPR-expressing neurons in the mediobasal hypothalamus that are not shielded by the BBB [30,31]. The existence of differential methods of regulation of leptin transport in the central nervous system (CNS) via the choroid plexus and the BBB has also been suggested. Specific high-affinity transport systems for leptin in the hypothalamus and across the choroid epithelium of the blood-cerebrospinal fluid (CSF) barrier seem to play a key role in regulating leptin entry into the CNS and CSF under physiological conditions. At higher pharmacological concentrations of leptin and over a longer period, transport via the BBB takes over [32]. Moreover, another study suggests that intact leptin could be partially transported from blood to the brain by a saturable system [33]. Leptin could also be transported by tanycytes within the mediobasal hypothalamus; however, this requires the expression of LEPR [34]. Moreover, a study on mice with inducible deletion of LEPR in brain endothelial and epithelial cells (LepRbeKO) showed that leptin uptake by the brain depends on the presence of LEPR in brain barriers [31]. The important role of LEPR isoforms in leptin uptake in the brain was also suggested in a study conducted on mice lacking all LEPR isoforms. In these animals, leptin uptake by the brain was significantly reduced [35]. However, the results of another study on a rat strain deficient in all LEPR isoforms showed that the expression of the LEPR gene was not important for leptin uptake in the brain [36]. Moreover, GH could enable leptin to act on metabolism. The influence of GH on metabolism was reported to occur in a manner that depends on leptin, among other hormones, and conditions that affect glucose homeostasis, including insulin sensitivity, appetite, energy expenditure, and neuroendocrine adaptation in response to different forms of metabolic stress, such as glucose deprivation, food restriction, and physical exercise [37,38]. Additionally, our results confirm that food deprivation increases the circulating concentration of GH in sheep. However, this effect was observed only during the SD photoperiod. The stimulating effect of food deprivation was stated before in both ruminants and humans [39]. Moreover, the study on sheep under long-term metabolic manipulation, which led to creating lean and fat animals, showed that the leptin concentration was significantly higher and GH concentration was higher in fat animals [40]. These season-dependent influences of food deprivation on the GH concentration may further support our results, suggesting that leptin modulates GH secretion in sheep only during the SD photoperiod. Since the sheep in this experiment were not fed immediately before and during the experiment (more than 12 h of food deprivation), it is possible there was a decrease in endogenous leptin production and, thus, a decrease in the inhibitory effect of this hormone on GH secretion in the pituitary gland.
Our study showed that LEPR is expressed both in the ARC and PVN, the regions of the hypothalamus involved in the central control of GH secretion from the pituitary. The pattern of LEPR gene expression in the ARC and AP was similar. This finding may suggest that the reduced sensitivity of the AP hypothalamic nucleus to leptin action occurs during the LD photoperiod. However, the results of our research showed different patterns for both seasonal and leptin treatment responses. In the PVN, LEPR mRNA expression did not appear to be affected by the length of the day, while the seasonally dependent effect of leptin treatment on the expression of this gene was demonstrated. This regulatory effect of leptin on LEPR mRNA expression in the PVN may be related to its role in regulating the activity of the sympathetic nervous system, in which leptin has been shown to play an important role [41,42]. Therefore, the decrease in LEPR mRNA expression during long days could act as a mechanism that enables adaptation to the physiological increase in leptin concentration during this period.
Moreover, our study showed that peripheral administration of leptin did not influence either GHRH or SST expression in the hypothalamus. These results are generally consistent with a previous experiment on mice, in which peripherally administered leptin did not alter hypothalamic GHRH and SST mRNA levels compared with vehicle-treated controls [18]. Additionally, in cows treated intracerebroventricularly with leptin, no changes in GHRH secretion into the CFS were found [43]. However, a study on rats showed that central leptin injection increased GHRH mRNA levels and reduced SST mRNA levels in the hypothalamus [44]. Interestingly, GHRH expression was higher during the LD photoperiod than during the SD period, and this observation was not consistent with the changes in the circulating concentration of GH. However, the previously mentioned study on cows also reported a weak correlation between the concentrations of GHRH in the CSF and serum concentrations of GH [43]. This could suggest that the photoperiodic condition influences GH secretion via mechanisms independent of the hypothalamic GH-regulatory hormones. However, the action of hypothalamic GH-regulatory hormones in the AP depends upon the expression of their corresponding receptor in pituitary cells. Our study suggests that the expression of GHRHR in the AP is generally constant and not influenced by leptin treatment or photoperiodical conditions, but the same cannot be said for the expression of the SST receptor. Earlier studies showed that SSTR2 and SSTR5 are two receptors that play an essential role in SST inhibitory action in HPS axis activity [45]. Research on rats showed that Sstr5 gene expression was confirmed in approximately 86% of somatotrophs, while Sstr2 expression was measured in approximately 42% of these cells [46]. Our research showed that during the SD season, when the GH serum concentration was higher, the expression of SSTR2 was more than 5-fold lower than during the LD photoperiod. It was previously found that SST signals predominantly through SSTR2, and the activation of this receptor via intact adenylate cyclase and mitogen-activated protein kinase systems mediates the inhibitory actions of SST [45,47]. Moreover, we found that the expression of SSTR5 mRNA in the AP was increased during the LD photoperiod as well as in SD conditions in animals treated with leptin. This finding may partially explain the reduced secretion of GH in ewes injected with leptin during the SD photoperiod. The SSTR5 gene is expressed in GH-releasing cells and plays a critical role in the physiological regulation of GH secretion [48]. However, it should be mentioned that research conducted on mice showed that the lack of Sstr2 and Sstr5 expression did not lead to an elevation in serum GH concentration, which may suggest a compensatory function of SSTR1 and SSTR3 [49,50,51,52]. Our study showed that leptin and photoperiodic conditions did not influence the gene expression of SSTR3; however, it was determined that, unlike SSTR2 and SSTR5, the expression of SSTR1 mRNA in the AP was suppressed during the LD photoperiod. Similar to the rest of the SST receptors, SSTR1 is involved in modulating GH secretion [53]. However, SSTR1 is expressed mainly in the gastrointestinal tract [54,55] and in brain tissue, and its activity could be masked by the action of SSTR2 and SSTR5, which are predominantly expressed in brain and endocrine cells. Therefore, the changes in SSTR1 expression may be less important for the sensitivity of the AP to SST action.

4. Material and Methods

4.1. Animals

Experiments were conducted on 24 2–3-year-old Polish Blackface ewes during different photoperiods: LD (May/June) and SD (November/December). During each photoperiod, the animals were randomly divided into two groups (6 ewes in each group):
  • Control—intravenously treated with 0.9% w/v NaCl (Baxter, Deerfield, IL, USA) in a volume equal to that used in the experimental group;
  • LEP—intravenously injected with ovine recombinant leptin (Protein Laboratories Rehovot (PLR) Ltd., Rehovot, Israel) at a dose of 20 µg/kg body weight suspended in saline (0.9% w/v NaCl, Baxter, Deerfield, IL, USA). The leptin dose was selected based on the dose used by Maciel et al. [56] for growing beef heifers.
During the experiments, the ewes were allowed to maintain eye contact and exposed to natural daylight and exposed to natural daylight. The ewes were fed commercial concentrates and hay and had ad libitum water access. Before the experiments, the estrous cycles of the ewes during the SD period were synchronized using a method based on intravaginal sponges—Chronogest® CR (Merck Animal Health, Amsterdam, The Netherlands) according to a previously described protocol [57]. Twenty-four hours before the experiment began, the animals were treated with 500 IU of pregnant mare serum gonadotropin (PMSG) (Merck Animal Health, Amsterdam, The Netherlands). During the LD period, the synchronization of animals was not performed because the ewes were in seasonal anestrous. At 12 h before the start of the experiments, the animals were deprived of food. Blood collection started 1.5 h before the leptin injection. Blood was collected in 30-min intervals until the end of the experiment. During the calculations, the results from the first three time points and the last four time points of blood collection were obtained from each animal.
The experiments lasted 4 h (1.5 h before followed by 2.5 h after leptin treatment), and then the animals were euthanized using a pharmacological agent, Morbital® (Biowet Puławy Sp. z.o.o; Puławy, Poland), which was administered intravenously at a dose of 80 mg/kg of body mass, and the AP and hypothalamic tissues were collected and snap frozen in liquid nitrogen. Until further analysis, the tissues were stored at −80 °C.
The experimental procedures were approved (authorization no. 56/2013 from 23 October 2013) by the 3rd Local Ethics Committee of the Warsaw University of Life Sciences—SGGW (Warsaw, Poland).

4.2. Real-Time (RT)-PCR Assay

Total RNA from collected tissues was isolated using a NucleoSpin RNA/Protein kit (Macherey-Nagel, Dueren, Germany). The quality and quantity of the RNA were verified using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) at wavelengths of 260, 280, and 230 nm and using 1% agarose gel electrophoresis. Subsequently, RNA was transcribed using a reverse transcription Maxima™ First Strand cDNA Synthesis Kit for Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) (Thermo Fisher Scientific, Waltham, MA, USA). The obtained matrix was used for real-time PCR using the FIREPol® HOT EvaGreen qPCR Mix® Plus kit (Solis Biodyne, Tartu, Estonia). The temperature profile for the amplification of each gene was chosen based on an optimized standard protocol: 95 °C for 15 min for HOT FIREPol® DNA polymerase activation and 40 cycles at 95 °C for 5–10 s for denaturation, 60 °C for 10–30 s for annealing, and 72 °C for 15–30 s for the extension. The primers used for each measured gene are presented in Table 3. The amplified products of the originally designed primers were sequenced to confirm their correct design. The PCR experiments were carried out using a thermocycler RotorGene Q (Qiagen, Germantown, MD, USA) with RotorGene Q software. The results obtained for the measured genes were normalized to the levels of the reference gene or the combination of the reference genes, including glyceraldehyde 3-phosphate dehydrogenase (GAPDH), β-actin (ACTB), histone deacetylase 1 (HDAC1), beta-2-microglobulin (B2M), and cyclophilin C (PPIC), using the NormFinder (Molecular Diagnostic Laboratory, Aarhus University Hospital, Aarhus, Denmark) program to identify of the optimal normalization gene. The results are presented in arbitrary units as the ratio of the expression of the target gene to the expression of the reference gene and the mean gene expression in the SD was set as 1 [58].

4.3. Radioimmunological Assay

The GH concentration in plasma was measured by the radioimmunological assay (RIA) double-antibody method using anti-bovine GH and anti-rabbit γ-globulin antisera and a bovine GH standard (NIDDK-GH-B-1003A). The characteristics of the antiserum and method were comprehensively described by Dvorak et al. [62]. The assay’s sensitivity for GH was 0.6 ng/mL, and the intra- and interassay coefficients of variation were 5.9 and 10.2%, respectively.

4.4. Statistical Analysis

The statistical analysis was performed using TIBCO Statistica 13.3 (TIBCO Statistica Ltd., Palo Alto, CA, USA). The significant differences in gene expression between the experimental groups were determined using a two-way analysis of variance (ANOVA) with the following factors: season or leptin treatment. The significance of the differences in blood GH concentration was determined using two-way ANOVA (comparison among the groups before or after treatment) or a Student’s t-test for dependent samples (comparison between before vs. after for each group separately). Each ANOVA was followed by Fisher’s post hoc test, and results p ≤ 0.05 were deemed statistically significant. Before each ANOVA, the normality (Shapiro-Wilk’s test) and variance homogeneity (Levene’s test) were evaluated. If the ANOVA assumptions were violated, the data were log-transformed. The data are presented as the mean ± standard error of the mean (SEM).

5. Conclusions

Our study shows that leptin influences the release of GH in a season-dependent manner, and its effect seems to be targeted at the posttranscriptional stages of GH secretion. The lack of effect of leptin treatment on GH secretion during the LD photoperiod may result from the suppressed expression of the gene encoding LEPR in the AP, which suggests that, during the LD photoperiod, leptin resistance occurs in this gland. Reduced expression of LEPR was also found in the ARC, while in the PVN, changes in LEPR expression in response to leptin treatment may suggest that seasonal changes in sensitivity to leptin occur in the hypothalamus. However, the lack of leptin-induced changes in the expression of GHRH and SST, regardless of the photoperiodic conditions, indicates that the effect of leptin on GH secretion is dependent upon changes in the secretion of hypothalamic GH regulatory hormones. Our findings suggest that the mechanism by which both leptin and photoperiod influence GH secretion in the AP is dependent upon changes in the sensitivity of pituitary cells to the actions of SST.

Author Contributions

Conceptualization, M.W.; formal analysis, M.W. and A.P.H.; investigation, A.K., A.P.H., M.W., and H.A.; data curation, M.W.; writing—original draft preparation, M.W., A.P.H., and A.K.; writing—review and editing, A.P.H., A.K., H.A., D.A.Z., and M.W.; visualization, M.W., and A.P.H.; supervision, A.P.H. and D.A.Z.; project administration, A.K. and M.W.; funding acquisition, A.K. and D.A.Z. All authors have read and agreed to the published version of the manuscript.

Funding

The research was supported by the Polish National Science Center grant ‘SONATA’ no. 2013/11/D/NZ9/02536.

Institutional Review Board Statement

All procedures involving animal welfare and care were approved by the 3rd Local Ethical Commission of Warsaw University of Life Sciences—SGGW (Warsaw, Poland, authorization no. 56/2013).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wójcik, M.; Krawczyńska, A.; Antushevich, H.; Herman, A. Post-Receptor Inhibitors of the GHR-JAK2-STAT Pathway in the Growth Hormone Signal Transduction. IJMS 2018, 19, 1843. [Google Scholar] [CrossRef]
  2. Tannenbaum, G.S.; Gurd, W.; Lapointe, M. Leptin Is a Potent Stimulator of Spontaneous Pulsatile Growth Hormone (GH) Secretion and the GH Response to GH-Releasing Hormone. Endocrinology 1998, 139, 3871–3875. [Google Scholar] [CrossRef]
  3. Zieba, D.; Amstalden, M.; Morton, S.; Gallino, J.; Edwards, J.; Harms, P.; Williams, G. Effects of Leptin on Basal and GHRH-Stimulated GH Secretion from the Bovine Adenohypophysis Are Dependent upon Nutritional Status. J. Endocrinol. 2003, 178, 83–89. [Google Scholar] [CrossRef] [PubMed]
  4. Fietta, P. Focus on Leptin, a Pleiotropic Hormone. Minerva Med. 2005, 96, 65–75. [Google Scholar] [PubMed]
  5. Obradovic, M.; Sudar-Milovanovic, E.; Soskic, S.; Essack, M.; Arya, S.; Stewart, A.J.; Gojobori, T.; Isenovic, E.R. Leptin and Obesity: Role and Clinical Implication. Front. Endocrinol. 2021, 12, 585887. [Google Scholar] [CrossRef]
  6. Watanobe, H.; Habu, S. Leptin Regulates Growth Hormone-Releasing Factor, Somatostatin, and α-Melanocyte-Stimulating Hormone But Not Neuropeptide Y Release in Rat Hypothalamus In Vivo: Relation with Growth Hormone Secretion. J. Neurosci. 2002, 22, 6265–6271. [Google Scholar] [CrossRef] [PubMed]
  7. Gruzdeva, O.; Borodkina, D.; Uchasova, E.; Dyleva, Y.; Barbarash, O. Leptin Resistance: Underlying Mechanisms and Diagnosis. Diabetes Metab. Syndr. Obes. Targets Ther. 2019, 12, 191–198. [Google Scholar] [CrossRef]
  8. Walton, J.C.; Weil, Z.M.; Nelson, R.J. Influence of Photoperiod on Hormones, Behavior, and Immune Function. Front. Neuroendocrinol. 2011, 32, 303–319. [Google Scholar] [CrossRef]
  9. Webster, J.R.; Corson, I.D.; Littlejohn, R.P.; Stuart, S.K.; Suttie, J.M. Effects of Season and Nutrition on Growth Hormone and Insulin-like Growth Factor-I in Male Red Deer. Endocrinology 1996, 137, 698–704. [Google Scholar] [CrossRef] [PubMed]
  10. Wójcik, M.; Herman, A.P.; Zieba, D.A.; Krawczyńska, A. The Impact of Photoperiod on the Leptin Sensitivity and Course of Inflammation in the Anterior Pituitary. IJMS 2020, 21, 4153. [Google Scholar] [CrossRef] [PubMed]
  11. Molik, E.; Misztal, T.; Romanowicz, K.; Zieba, D. Short-Day and Melatonin Effects on Milking Parameters, Prolactin Profiles and Growth-Hormone Secretion in Lactating Sheep. Small Rumin. Res. 2013, 109, 182–187. [Google Scholar] [CrossRef]
  12. Misztal, T.; Romanowicz, K.; Barcikowski, B. Seasonal Changes of Melatonin Secretionin Relation to the Reproductive Cycle in Sheep. J. Anim. Feed Sci. 1996, 5, 35–48. [Google Scholar] [CrossRef]
  13. Szczesna, M.; Zieba, D.A. Phenomenon of Leptin Resistance in Seasonal Animals: The Failure of Leptin Action in the Brain. Domest. Anim. Endocrinol. 2015, 52, 60–70. [Google Scholar] [CrossRef] [PubMed]
  14. Zieba, D.A.; Klocek, B.; Williams, G.L.; Romanowicz, K.; Boliglowa, L.; Wozniak, M. In Vitro Evidence That Leptin Suppresses Melatonin Secretion during Long Days and Stimulates Its Secretion during Short Days in Seasonal Breeding Ewes. Domest. Anim. Endocrinol. 2007, 33, 358–365. [Google Scholar] [CrossRef] [PubMed]
  15. Szczesna, M.; Zieba, D.A.; Klocek-Gorka, B.; Misztal, T.; Stepien, E. Seasonal Effects of Central Leptin Infusion and Prolactin Treatment on Pituitary SOCS-3 Gene Expression in Ewes. J. Endocrinol. 2011, 208, 81–88. [Google Scholar] [CrossRef]
  16. Buonfiglio, D.; Parthimos, R.; Dantas, R.; Cerqueira Silva, R.; Gomes, G.; Andrade-Silva, J.; Ramos-Lobo, A.; Amaral, F.G.; Matos, R.; Sinésio, J.; et al. Melatonin Absence Leads to Long-Term Leptin Resistance and Overweight in Rats. Front. Endocrinol. 2018, 9, 122. [Google Scholar] [CrossRef]
  17. Buonfiglio, D.; Tchio, C.; Furigo, I.; Donato, J.; Baba, K.; Cipolla-Neto, J.; Tosini, G. Removing Melatonin Receptor Type 1 Signaling Leads to Selective Leptin Resistance in the Arcuate Nucleus. J. Pineal. Res. 2019, 67, e12580. [Google Scholar] [CrossRef]
  18. Luque, R.M.; Huang, Z.H.; Shah, B.; Mazzone, T.; Kineman, R.D. Effects of Leptin Replacement on Hypothalamic-Pituitary Growth Hormone Axis Function and Circulating Ghrelin Levels in Ob/Ob Mice. Am. J. Physiol.-Endocrinol. Metab. 2007, 292, E891–E899. [Google Scholar] [CrossRef]
  19. Nagatani, S.; Zeng, Y.; Keisler, D.H.; Foster, D.L.; Jaffe, C.A. Leptin Regulates Pulsatile Luteinizing Hormone and Growth HormoneSecretion in the Sheep**This Work Was Supported by a V.A. Merit Award (to C.A.J.), NIH Grants HD-18258 and HD-18394 (to D.L.F.), and Michigan Diabetes Research and Training Center Grant 2P60-DK-20572-21. A Preliminary Report of This Work Was Presented at the 82nd Annual Meeting of The Endocrine Society. Endocrinology 2000, 141, 3965–3975. [Google Scholar] [CrossRef]
  20. Chen, C.; Roh, S.-G.; Nie, G.-Y.; Loneragan, K.; Xu, R.-W.; Ruan, M.; Clarke, I.J.; Goding, J.W.; Gertler, A. The In Vitro Effect of Leptin on Growth Hormone Secretion from Primary Cultured Ovine Somatotrophs. ENDO 2001, 14, 073–078. [Google Scholar] [CrossRef]
  21. Mizuno, I.; Okimura, Y.; Takahashi, Y.; Kaji, H.; Abe, H.; Chihara, K. Leptin Stimulates Basal and GHRH-Induced GH Release from Cultured Rat Anterior Pituitary Cells in Vitro. Kobe J. Med. Sci. 1999, 45, 221–227. [Google Scholar] [PubMed]
  22. Roh, S.-G.; Nie, G.-Y.; Loneragan, K.; Gertler, A.; Chen, C. Direct Modification of Somatotrope Function by Long-Term Leptin Treatment of Primary Cultured Ovine Pituitary Cells. Endocrinology 2001, 142, 5167–5171. [Google Scholar] [CrossRef] [PubMed]
  23. Liu, Y.; Zhong, Y.; Pei, J.; Zhu, Y.; Hu, Y.; Chi, S.; Kaye, A.D. Inhibitory Effect of Leptin on Growth Hormone Secretion of GH3 Cells: Involvement of Cell Proliferation, Apoptosis and Intracellular Free Ca2+. Cytokine 2009, 46, 245–250. [Google Scholar] [CrossRef]
  24. Roh, S.-G.; Clarke, I.J.; Xu, R.-W.; Goding, J.W.; Loneragan, K.; Chen, C. The in Vitro Effect of Leptin OnBasal and Growth Hormone-Releasing Hormone-StimulatedGrowth Hormone Secretion from TheOvine Pituitary Gland. Neuroendocrinology 1998, 68, 361–364. [Google Scholar] [CrossRef] [PubMed]
  25. Krawczyńska, A.; Herman, A.P.; Antushevich, H.; Bochenek, J.; Wojtulewicz, K.; Zieba, D.A. The Effect of Leptin on the Blood Hormonal Profile (Cortisol, Insulin, Thyroid Hormones) of the Ewe in Acute Inflammation in Two Different Photoperiodical Conditions. IJMS 2022, 23, 8109. [Google Scholar] [CrossRef]
  26. Marie, M.; Findlay, P.; Thomas, L.; Adam, C. Daily Patterns of Plasma Leptin in Sheep: Effects of Photoperiod and Food Intake. J. Endocrinol. 2001, 170, 277–286. [Google Scholar] [CrossRef]
  27. Szczesna, M.; Zieba, D.A.; Klocek-Gorka, B.; Keisler, D.H. Interactive in Vitro Effect of Prolactin, Growth Hormone and Season on Leptin Secretion by Ovine Adipose Tissue. Small Rumin. Res. 2011, 100, 177–183. [Google Scholar] [CrossRef]
  28. Jin, L.; Burguera, B.G.; Couce, M.E.; Scheithauer, B.W.; Lamsan, J.; Eberhardt, N.L.; Kulig, E.; Lloyd, R.V. Leptin and Leptin Receptor Expression in Normal and Neoplastic Human Pituitary: Evidence of a Regulatory Role for Leptin on Pituitary Cell Proliferation. J. Clin. Endocrinol. Metab. 1999, 84, 2903–2911. [Google Scholar] [CrossRef]
  29. Allensworth-James, M.L.; Odle, A.; Haney, A.; Childs, G. Sex Differences in Somatotrope Dependency on Leptin Receptors in Young Mice: Ablation of LEPR Causes Severe Growth Hormone Deficiency and Abdominal Obesity in Males. Endocrinology 2015, 156, 3253–3264. [Google Scholar] [CrossRef] [PubMed]
  30. Faouzi, M.; Leshan, R.; Björnholm, M.; Hennessey, T.; Jones, J.; Münzberg, H. Differential Accessibility of Circulating Leptin to Individual Hypothalamic Sites. Endocrinology 2007, 148, 5414–5423. [Google Scholar] [CrossRef] [PubMed]
  31. Di Spiezio, A.; Sandin, E.S.; Dore, R.; Müller-Fielitz, H.; Storck, S.E.; Bernau, M.; Mier, W.; Oster, H.; Jöhren, O.; Pietrzik, C.U.; et al. The LepR-Mediated Leptin Transport across Brain Barriers Controls Food Reward. Mol. Metab. 2018, 8, 13–22. [Google Scholar] [CrossRef]
  32. Zlokovic, B.V.; Jovanovic, S.; Miao, W.; Samara, S.; Verma, S.; Farrell, C.L. Differential Regulation of Leptin Transport by the Choroid Plexus and Blood-Brain Barrier and High Affinity Transport Systems for Entry into Hypothalamus and across the Blood-Cerebrospinal Fluid Barrier. Endocrinology 2000, 141, 1434–1441. [Google Scholar] [CrossRef]
  33. Banks, W.A.; Kastin, A.J.; Huang, W.; Jaspan, J.B.; Maness, L.M. Leptin Enters the Brain by a Saturable System Independent of Insulin. Peptides 1996, 17, 305–311. [Google Scholar] [CrossRef] [PubMed]
  34. Balland, E.; Dam, J.; Langlet, F.; Caron, E.; Steculorum, S.; Messina, A.; Rasika, S.; Falluel-Morel, A.; Anouar, Y.; Dehouck, B.; et al. Hypothalamic Tanycytes Are an ERK-Gated Conduit for Leptin into the Brain. Cell. Metab. 2014, 19, 293–301. [Google Scholar] [CrossRef] [PubMed]
  35. Hileman, S.M.; Pierroz, D.D.; Masuzaki, H.; Bjørbaek, C.; El-Haschimi, K.; Banks, W.A.; Flier, J.S. Characterizaton of Short Isoforms of the Leptin Receptor in Rat Cerebral Microvessels and of Brain Uptake of Leptin in Mouse Models of Obesity. Endocrinology 2002, 143, 775–783. [Google Scholar] [CrossRef] [PubMed]
  36. Banks, W.A.; Niehoff, M.L.; Martin, D.; Farrell, C.L. Leptin Transport across the Blood-Brain Barrier of the Koletsky Rat Is Not Mediated by a Product of the Leptin Receptor Gene. Brain Res. 2002, 950, 130–136. [Google Scholar] [CrossRef] [PubMed]
  37. Tavares, M.R.; Frazao, R.; Donato, J. Understanding the Role of Growth Hormone in Situations of Metabolic Stress. J. Endocrinol. 2023, 256, e220159. [Google Scholar] [CrossRef]
  38. Donato, J.; Wasinski, F.; Furigo, I.C.; Metzger, M.; Frazão, R. Central Regulation of Metabolism by Growth Hormone. Cells 2021, 10, 129. [Google Scholar] [CrossRef]
  39. Hull, K.; Harvey, S. GH as a Co-Gonadotropin: The Relevance of Correlative Changes in GH Secretion and Reproductive State. J. Endocrinol. 2002, 172, 1–19. [Google Scholar] [CrossRef]
  40. Zieba, D.A.; Biernat, W.; Szczesna, M.; Kirsz, K.; Barć, J.; Misztal, T. Changes in Expression of the Genes for the Leptin Signaling in Hypothalamic-Pituitary Selected Areas and Endocrine Responses to Long-Term Manipulation in Body Weight and Resistin in Ewes. IJMS 2020, 21, 4238. [Google Scholar] [CrossRef]
  41. Shi, Z.; Pelletier, N.E.; Wong, J.; Li, B.; Sdrulla, A.D.; Madden, C.J.; Marks, D.L.; Brooks, V.L. Leptin Increases Sympathetic Nerve Activity via Induction of Its Own Receptor in the Paraventricular Nucleus. eLife 2020, 9, e55357. [Google Scholar] [CrossRef] [PubMed]
  42. Shi, Z.; Brooks, V.L. Leptin Differentially Increases Sympathetic Nerve Activity and Its Baroreflex Regulation in Female Rats: Role of Oestrogen: Leptin Increases Sympathetic Nerve Activity in Females. J. Physiol. 2015, 593, 1633–1647. [Google Scholar] [CrossRef] [PubMed]
  43. Thomas, M.G.; Amstalden, M.; Hallford, D.M.; Silver, G.A.; Garcia, M.D.; Keisler, D.H.; Williams, G.L. Dynamics of GHRH in Third-Ventricle Cerebrospinal Fluid of Cattle: Relationship with Serum Concentrations of GH and Responses to Appetite-Regulating Peptides. Domest. Anim. Endocrinol. 2009, 37, 196–205. [Google Scholar] [CrossRef] [PubMed]
  44. Cocchi, D.; De Gennaro Colonna, V.; Bagnasco, M.; Bonacci, D.; Muller, E. Leptin Regulates GH Secretion in the Rat by Acting on GHRH and Somatostatinergic Functions. J. Endocrinol. 1999, 162, 95–99. [Google Scholar] [CrossRef] [PubMed]
  45. Córdoba-Chacón, J.; Gahete, M.D.; Culler, M.D.; Castaño, J.P.; Kineman, R.D.; Luque, R.M. Somatostatin Dramatically Stimulates Growth Hormone Release from Primate Somatotrophs Acting at Low Doses Via Somatostatin Receptor 5 and Cyclic AMP: Direct Effects of Somatostatin on GH Release. J. Neuroendocrinol. 2012, 24, 453–463. [Google Scholar] [CrossRef]
  46. Kumar, U.; Laird, D.; Srikant, C.B.; Escher, E.; Patel, Y.C. Expression of the Five Somatostatin Receptor (SSTR1-5) Subtypes in Rat Pituitary Somatotrophes: Quantitative Analysis by Double-Label Immunofluorescence Confocal Microscopy. Endocrinology 1997, 138, 4473–4476. [Google Scholar] [CrossRef]
  47. Ben-Shlomo, A.; Pichurin, O.; Khalafi, R.; Zhou, C.; Chesnokova, V.; Ren, S.-G.; Liu, N.-A.; Melmed, S. Constitutive Somatostatin Receptor Subtype 2 Activity Attenuates GH Synthesis. Endocrinology 2013, 154, 2399–2409. [Google Scholar] [CrossRef]
  48. Shimon, I.; Taylor, J.E.; Dong, J.Z.; Bitonte, R.A.; Kim, S.; Morgan, B.; Coy, D.H.; Culler, M.D.; Melmed, S. Somatostatin Receptor Subtype Specificity in Human Fetal Pituitary Cultures. Differential Role of SSTR2 and SSTR5 for Growth Hormone, Thyroid-Stimulating Hormone, and Prolactin Regulation. J. Clin. Investig. 1997, 99, 789–798. [Google Scholar] [CrossRef]
  49. Eigler, T.; Ben-Shlomo, A.; Zhou, C.; Khalafi, R.; Ren, S.-G.; Melmed, S. Constitutive Somatostatin Receptor Subtype-3 Signaling Suppresses Growth Hormone Synthesis. Mol. Endocrinol. 2014, 28, 554–564. [Google Scholar] [CrossRef]
  50. Zheng, H.; Bailey, A.; Jiang, M.-H.; Honda, K.; Chen, H.Y.; Trumbauer, M.E.; Van der Ploeg, L.H.T.; Schaeffer, J.M.; Leng, G.; Smith, R.G. Somatostatin Receptor Subtype 2 Knockout Mice Are Refractory to Growth Hormone-Negative Feedback on Arcuate Neurons. Mol. Endocrinol. 1997, 11, 1709–1717. [Google Scholar] [CrossRef]
  51. Norman, M.; Moldovan, S.; Seghers, V.; Wang, X.-P.; DeMayo, F.J.; Brunicardi, F.C. Sulfonylurea Receptor Knockout Causes Glucose Intolerance in Mice That Is Not Alleviated by Concomitant Somatostatin Subtype Receptor 5 Knockout. Ann. Surg. 2002, 235, 767–774. [Google Scholar] [CrossRef] [PubMed]
  52. Luque, R.M.; Gahete, M.D.; Hochgeschwender, U.; Kineman, R.D. Evidence That Endogenous SST Inhibits ACTH and Ghrelin Expression by Independent Pathways. Am. J. Physiol.-Endocrinol. Metab. 2006, 291, E395–E403. [Google Scholar] [CrossRef] [PubMed]
  53. Kreienkamp, H.J.; Akgün, E.; Baumeister, H.; Meyerhof, W.; Richter, D. Somatostatin Receptor Subtype 1 Modulates Basal Inhibition of Growth Hormone Release in Somatotrophs. FEBS Lett. 1999, 462, 464–466. [Google Scholar] [CrossRef] [PubMed]
  54. Modarai, S.R.; Opdenaker, L.M.; Viswanathan, V.; Fields, J.Z.; Boman, B.M. Somatostatin Signaling via SSTR1 Contributes to the Quiescence of Colon Cancer Stem Cells. BMC Cancer 2016, 16, 941. [Google Scholar] [CrossRef]
  55. Schäfer, J.; Meyerhof, W. Sst1 MRNA Is the Prominent Somatostatin Receptor MRNA in the Rat Gastrointestinal Tract: Reverse Transcription Polymerase Chain Reaction and in Situ-Hybridization Study. Neuropeptides 1999, 33, 457–463. [Google Scholar] [CrossRef]
  56. Maciel, M.N.; Zieba, D.A.; Amstalden, M.; Keisler, D.H.; Neves, J.P.; Williams, G.L. Chronic Administration of Recombinant Ovine Leptin in Growing Beef Heifers: Effects on Secretion of LH, Metabolic Hormones, and Timing of Puberty1. J. Anim. Sci. 2004, 82, 2930–2936. [Google Scholar] [CrossRef]
  57. Przybył, B.; Wójcik-Gładysz, A.; Gajewska, A.; Szlis, M. Brain-Derived Neurotrophic Factor (BDNF) Affects Somatotrophicaxis Activity in Sheep. J. Anim. Feed Sci. 2021, 30, 329–339. [Google Scholar] [CrossRef]
  58. Szczepkowska, A.; Bochenek, J.; Wójcik, M.; Tomaszewska-Zaremba, D.; Antushevich, H.; Tomczyk, M.; Skipor, J.; Herman, A. Effect of Caffeine on Adenosine and Ryanodine Receptorgene Expression in the Hypothalamus, Pituitary, and Choroidplexus in Ewes under Basal and LPS Challenge Conditions. J. Anim. Feed Sci. 2022, 32, 17–25. [Google Scholar] [CrossRef]
  59. Krawczyńska, A.; Herman, A.P.; Antushevich, H.; Bochenek, J.; Wojtulewicz, K.; Zięba, D.A. The Influence of Photoperiod on the Action of Exogenous Leptin on Gene Expression of Proinflammatory Cytokines and Their Receptors in the Thoracic Perivascular Adipose Tissue (PVAT) in Ewes. Mediat. Inflamm. 2019, 2019, 7129476. [Google Scholar] [CrossRef]
  60. Krawczyńska, A.; Antushevich, H.; Bochenek, J.; Wojtulewicz, K.; Pawlina, B.; Herman, A.; Zięba, D. Photoperiodic Conditions as a Factor Modulating Leptin Influence on Pro-Inflammatory Cytokines and Their Receptors Gene Expression in Ewe’s Aorta. J. Anim. Feed. Sci. 2019, 28, 128–137. [Google Scholar] [CrossRef]
  61. Haziak, K.; Herman, A.P.; Tomaszewska-Zaremba, D. Effects of Central Injection of Anti-LPS Antibody and Blockade of TLR4 on GnRH/LH Secretion during Immunological Stress in Anestrous Ewes. Mediat. Inflamm. 2014, 2014, 867170. [Google Scholar] [CrossRef] [PubMed]
  62. Dvorak, P.; Becka, S.; Krejci, P.; Chrpova, M. Radioimmunoassay of Bovine Growth Hormone. Radiochem. Radioanal. Lett. 1978, 34, 155–159. [Google Scholar]
Ijms 24 08036 g001 550
Figure 1. The effect of season and leptin treatment on the plasma GH concentration before and after leptin treatment. GH—growth hormone, SD—short day; LD—long day; * shows the statistically significant differences between before and after treatment with the research factor; Capital letters show differences between the results from each period (separately before and after); lowercase letters refer to statistically significant differences in the period ‘before’; uppercase letters refers to statistically significant differences in the period ‘after’. The ‘before’ results were calculated from the three (means) and the ‘after’—last four (means) time points of blood collection intervals, based on the results obtained from each animal (present in the point chart).
Figure 1. The effect of season and leptin treatment on the plasma GH concentration before and after leptin treatment. GH—growth hormone, SD—short day; LD—long day; * shows the statistically significant differences between before and after treatment with the research factor; Capital letters show differences between the results from each period (separately before and after); lowercase letters refer to statistically significant differences in the period ‘before’; uppercase letters refers to statistically significant differences in the period ‘after’. The ‘before’ results were calculated from the three (means) and the ‘after’—last four (means) time points of blood collection intervals, based on the results obtained from each animal (present in the point chart).
Ijms 24 08036 g001
Table
Table 1. The relative expression of growth hormone-releasing hormone (GHRH), leptin receptor (LEPR), and somatostatin (SST) genes in hypothalamic structures, including the arcuate nucleus and paraventricular nucleus. Letters indicate significant differences between the groups, and the results are presented in arbitrary units.
Table 1. The relative expression of growth hormone-releasing hormone (GHRH), leptin receptor (LEPR), and somatostatin (SST) genes in hypothalamic structures, including the arcuate nucleus and paraventricular nucleus. Letters indicate significant differences between the groups, and the results are presented in arbitrary units.
Hypothalamic StructureGeneControl SDLeptin SDControl LDLeptin LD
Arcuate nucleus (ARC)GHRH1 ± 0.08 A1.2 ± 0.04 A1.54 ± 0.11 B1.72 ± 0.14 B
LEPR1 ± 0.24 B0.95 ± 0.17 B0.58 ± 0.03 A0.66 ± 0.09 A
Paraventricular nucleus (PVN)SST1 ± 0.09 A1.17 ± 0.15 AB1.81 ± 0.4 B1.3 ± 0.19 AB
LEPR1 ± 0.13 B1.31 ± 0.11 C0.91 ± 0.03 B0.6 ± 0.08 A
Table
Table 2. The relative gene expression of the following proteins: growth hormone-releasing hormone receptor (GHRHR), somatostatin receptor 1 (SSTR1), somatostatin receptor 2 (SSTR2), somatostatin receptor 3 (SSTR3), somatostatin receptor 5 (SSTR5), growth hormone (GH), and leptin receptor (LEPR) in the ovine anterior pituitary. Letters indicate significant differences between the groups, and the results are presented in arbitrary units.
Table 2. The relative gene expression of the following proteins: growth hormone-releasing hormone receptor (GHRHR), somatostatin receptor 1 (SSTR1), somatostatin receptor 2 (SSTR2), somatostatin receptor 3 (SSTR3), somatostatin receptor 5 (SSTR5), growth hormone (GH), and leptin receptor (LEPR) in the ovine anterior pituitary. Letters indicate significant differences between the groups, and the results are presented in arbitrary units.
GeneAnterior Pituitary
Control SDLeptin SDControl LDLeptin LD
GHRHR1 ± 0.060.92 ± 0.10.90 ± 0.101.00 ± 0.08
SSTR11 ± 0.07 B1.19 ± 0.13 B0.37 ± 0.03 A0.43 ± 0.05 A
SSTR21 ± 0.32 A0.69 ± 0.13 A5.45 ± 0.77 B7.51 ± 0.61 C
SSTR31 ± 0.080.90 ± 0.071.01 ± 0.091.03 ± 0.04
SSTR51 ± 0.080.90 ± 0.071.01 ± 0.091.03 ± 0.04
GH1 ± 0.06 B1.05 ± 0.03 B0.81 ± 0.06 A0.7 ± 0.05 A
LEPR1 ± 0.19 B1 ± 0.12 B0.57 ± 0.14 A0.55 ± 0.08 A
Table
Table 3. Primer descriptions.
Table 3. Primer descriptions.
Gene SymbolPrimerGene Bank Accession NumberReferences
ForwardReverse
GHTTCCTCAGCAGAGTCTTCACCGGGGTAACATCTTCCAGCTCXM_027973953.1Originally designed
GHRACTGTTAGCCCAAGTATTCCATATGGCAAGTTCAGTGAGGXM_012096677.3Originally designed
GHRHCCTCTCAGGATTCCACGGTACGTACCTTTGCTCCTTGCTCXM_027976451.1Originally designed
GHRHRCTTCTCTCACTTCAGCTTGGGGATTTCTCCTTCAGTCAGCNM_001009454.3Originally designed
SSTCTCCATCGTCCTGGCTCTTAGTACTTGGCCAGTTCCTGTTTXM_027966037.1Originally designed
SSTR1ACTCCATGGTCATCTACGTGGAAGCAATGTGGAGGTGACXM_012098844.3Originally designed
SSTR2TCTCTCTGCTGGTCATCTTGCGTAGATGATGAACCCTGTGXM_004013144.4Originally designed
SSTR3CACTGGTCTATCTGGTGGTGTTGAGGATGTAGACATTGGTGXM_004006732.4Originally designed
SSTR5TGGTCATCTATGTGGTCCTGAGTAGGAGATGGCGTTTTGNM_001009265.1Originally designed
LEPRCTGTGCCAACAGCCAAACTGTGGATCAGGCTTCACAACANM_001009763.1[59]
ACTBGCCAACCGTGAGAAGATGACTCCATCACGATGCCAGTGNM_001009784.2[60]
GAPDHTGACCCCTTCATTGACCTTCGATCTCGCTCCTGGAAGATGNM_001190390.1[61]
HDAC1CTGGGGACCTACGGGATATTGACATGACCGGCTTGAAAATXM_004005023.3[58]
PPICTGGCACTGGTGGTATAAGCAGGGCTTGGTCAAGGTGATAAXM_004008676.5[61]
B2MCTTCTGTCCCACGCTGAGTTGGTGCTTAGAGGTCTCGXM_012180604.3Originally designed
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wójcik, M.; Krawczyńska, A.; Zieba, D.A.; Antushevich, H.; Herman, A.P. Influence of Leptin on the Secretion of Growth Hormone in Ewes under Different Photoperiodic Conditions. Int. J. Mol. Sci. 2023, 24, 8036. https://doi.org/10.3390/ijms24098036

AMA Style

Wójcik M, Krawczyńska A, Zieba DA, Antushevich H, Herman AP. Influence of Leptin on the Secretion of Growth Hormone in Ewes under Different Photoperiodic Conditions. International Journal of Molecular Sciences. 2023; 24(9):8036. https://doi.org/10.3390/ijms24098036

Chicago/Turabian Style

Wójcik, Maciej, Agata Krawczyńska, Dorota Anna Zieba, Hanna Antushevich, and Andrzej Przemysław Herman. 2023. "Influence of Leptin on the Secretion of Growth Hormone in Ewes under Different Photoperiodic Conditions" International Journal of Molecular Sciences 24, no. 9: 8036. https://doi.org/10.3390/ijms24098036

APA Style

Wójcik, M., Krawczyńska, A., Zieba, D. A., Antushevich, H., & Herman, A. P. (2023). Influence of Leptin on the Secretion of Growth Hormone in Ewes under Different Photoperiodic Conditions. International Journal of Molecular Sciences, 24(9), 8036. https://doi.org/10.3390/ijms24098036

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop